NEXGEL Reports Fourth Quarter and Full Year 2022 Financial Results
March 27, 2023 16:05 ET
|
NEXGEL, INC.
2022 revenue increased 32% YoY to $2.05 million, while gross profit margin improved As of December 31, 2022, had over $6.6 million in cash and securities which is sufficient to operate through 2025 ...
NEXGEL to Report Fourth Quarter and Full Year 2022 Financial Results on March 27th
March 15, 2023 07:30 ET
|
NEXGEL, INC.
Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., March 15, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading...
NEXGEL Partners with Former Major League Lacrosse Player, Greg “The Beast” Gurenlian, and The Face-Off Academy to Fight Turf Burn with Turfguard
March 07, 2023 07:30 ET
|
NEXGEL, INC.
Gurenlian and his training camp to use NEXGEL’s Turfguard for turf burn in lacrosse LANGHORNE, Pa., March 07, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (NASDAQ: NXGL, NXGLW), (“NEXGEL” or the...
NEXGEL Acquires 50% Interest in Newly Formed Joint Venture with C.G. Laboratories for Converting and Packaging Business
March 02, 2023 08:30 ET
|
NEXGEL, INC.
Strategic investment in CG Labs’ revenue generating and already profitable business increases NEXGEL’s capacity, improves margins and streamlines supply chain LANGHORNE, Pa., March 02, 2023 (GLOBE...
NEXGEL Launches Turfguard to Treat Painful Turf Burns and Protect Sports-Related Wounds
December 08, 2022 07:30 ET
|
NEXGEL, INC.
LANGHORNE, Pa., Dec. 08, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (NASDAQ: NXGL, NXGLW), (“NEXGEL” or the “Company”), a leading provider of ultra-gentle, high-water-content hydrogel products for...
NEXGEL Reports Third Quarter 2022 Financial Results
November 08, 2022 16:11 ET
|
NEXGEL, INC.
Revenue increased 69.6% YoY while gross profit margin improved both sequentially and YoY to 26% LANGHORNE, Pa., Nov. 08, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ:...
NEXGEL to Report Third Quarter 2022 Financial Results on November 8th
November 02, 2022 09:00 ET
|
NEXGEL, INC.
Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., Nov. 02, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading...
NEXGEL Reports Positive Results from Proof-of-Concept Study for its Diclofenac Hydrogel Pain Treatment
October 25, 2022 08:00 ET
|
NEXGEL, INC.
LANGHORNE, Pa., Oct. 25, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for...
NEXGEL Develops New Hydrogel Patch to Treat Amblyopia
October 20, 2022 08:00 ET
|
NEXGEL, INC.
Patch Will Be Available to Ophthalmologists and Optometrists in 1H 2023 Global Amblyopia Market Expected to Reach Over $6 Billion by 2027 LANGHORNE, Pa., Oct. 20, 2022 (GLOBE NEWSWIRE) -- NEXGEL,...
NEXGEL to Participate in Upcoming Investor Conferences in October 2022
October 04, 2022 07:30 ET
|
NEXGEL, INC.
LANGHORNE, Pa., Oct. 04, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for...